Sitemap
Posts
- Category: Hypoxia (continued)
- Category: Inflammatory bowel disease
- Complementary and alternative medicine use by patients with inflammatory bowel disease (Part 1)
- Complementary and alternative medicine use by patients with inflammatory bowel disease (Part 2)
- Complementary and alternative medicine use by patients with inflammatory bowel disease (Part 3)
- Complementary and alternative medicine use by patients with inflammatory bowel disease (Part 4)
- Complementary and alternative medicine use by patients with inflammatory bowel disease (Part 5)
- Complementary and alternative medicine use by patients with inflammatory bowel disease (Part 6)
- Use and nonuse of CAM for IBD (Part 1)
- Use and nonuse of CAM for IBD (Part 2)
- Use and nonuse of CAM for IBD (Part 3)
- Category: Inhaled Corticosteroids
- Systemic Bioavailability and Potency of High-Dose Inhaled Corticosteroids
- Systemic Bioavailability and Potency of High-Dose Inhaled Corticosteroids: Conclusion
- Systemic Bioavailability and Potency of High-Dose Inhaled Corticosteroids: Cortisol level
- Systemic Bioavailability and Potency of High-Dose Inhaled Corticosteroids: Discussion
- Systemic Bioavailability and Potency of High-Dose Inhaled Corticosteroids: Materials and Methods
- Systemic Bioavailability and Potency of High-Dose Inhaled Corticosteroids: Outcome
- Systemic Bioavailability and Potency of High-Dose Inhaled Corticosteroids: Potency of drugs
- Systemic Bioavailability and Potency of High-Dose Inhaled Corticosteroids: Protocol
- Systemic Bioavailability and Potency of High-Dose Inhaled Corticosteroids: Results
- Category: L-ferritin gene
- A point mutation in the iron-responsive element of the L-ferritin gene (Part 1)
- A point mutation in the iron-responsive element of the L-ferritin gene (Part 2)
- A point mutation in the iron-responsive element of the L-ferritin gene: Case presentation
- A point mutation in the iron-responsive element of the L-ferritin gene: DNA analysis
- Category: Leydig Cells
- Category: Lung Biopsy
- The Utility of Open Lung Biopsy in Patients Requiring Mechanical Ventilation
- The Utility of Open Lung Biopsy in Patients Requiring Mechanical Ventilation: Conclusion
- The Utility of Open Lung Biopsy in Patients Requiring Mechanical Ventilation: Discussion
- The Utility of Open Lung Biopsy in Patients Requiring Mechanical Ventilation: Histological Diagnosis
- The Utility of Open Lung Biopsy in Patients Requiring Mechanical Ventilation: Materials and Methods
- The Utility of Open Lung Biopsy in Patients Requiring Mechanical Ventilation: Results
- The Utility of Open Lung Biopsy in Patients Requiring Mechanical Ventilation: Ventilator-dependent patients
- Category: Lung Disease
- Pulmonary Vascular Hemodynamics in Chronic Lung Disease Patients
- Pulmonary Vascular Hemodynamics in Chronic Lung Disease Patients: Awake Data
- Pulmonary Vascular Hemodynamics in Chronic Lung Disease Patients: Conclusion
- Pulmonary Vascular Hemodynamics in Chronic Lung Disease Patients: Discussion
- Pulmonary Vascular Hemodynamics in Chronic Lung Disease Patients: FRC
- Pulmonary Vascular Hemodynamics in Chronic Lung Disease Patients: Materials and Methods
- Pulmonary Vascular Hemodynamics in Chronic Lung Disease Patients: Outcome
- Pulmonary Vascular Hemodynamics in Chronic Lung Disease Patients: Pulmonary Function and Gas Exchange
- Pulmonary Vascular Hemodynamics in Chronic Lung Disease Patients: Recurrent NOD
- Pulmonary Vascular Hemodynamics in Chronic Lung Disease Patients: Results
- Pulmonary Vascular Hemodynamics in Chronic Lung Disease Patients: RVEF
- Category: Lung function
- Efficacy of Positive vs Negative Pressure Ventilation in Unloading the Respiratory Muscles (1)
- Efficacy of Positive vs Negative Pressure Ventilation in Unloading the Respiratory Muscles (2)
- Efficacy of Positive vs Negative Pressure Ventilation in Unloading the Respiratory Muscles: Discussion (1)
- Efficacy of Positive vs Negative Pressure Ventilation in Unloading the Respiratory Muscles: Discussion (2)
- Efficacy of Positive vs Negative Pressure Ventilation in Unloading the Respiratory Muscles: Discussion (3)
- Efficacy of Positive vs Negative Pressure Ventilation in Unloading the Respiratory Muscles: Discussion (4)
- Efficacy of Positive vs Negative Pressure Ventilation in Unloading the Respiratory Muscles: Discussion (5)
- Efficacy of Positive vs Negative Pressure Ventilation in Unloading the Respiratory Muscles: Methods (1)
- Efficacy of Positive vs Negative Pressure Ventilation in Unloading the Respiratory Muscles: Methods (2)
- Efficacy of Positive vs Negative Pressure Ventilation in Unloading the Respiratory Muscles: Methods (3)
- Efficacy of Positive vs Negative Pressure Ventilation in Unloading the Respiratory Muscles: Methods (4)
- Efficacy of Positive vs Negative Pressure Ventilation in Unloading the Respiratory Muscles: Results (1)
- Efficacy of Positive vs Negative Pressure Ventilation in Unloading the Respiratory Muscles: Results (2)
- Efficacy of Positive vs Negative Pressure Ventilation in Unloading the Respiratory Muscles: Results (3)
- Lung function measured by impulse oscillometry and spirometry following eucapnic voluntary hyperventilation (1)
- Lung function measured by impulse oscillometry and spirometry following eucapnic voluntary hyperventilation (2)
- Lung function measured by impulse oscillometry and spirometry following eucapnic voluntary hyperventilation: DISCUSSION (1)
- Lung function measured by impulse oscillometry and spirometry following eucapnic voluntary hyperventilation: DISCUSSION (2)
- Lung function measured by impulse oscillometry and spirometry following eucapnic voluntary hyperventilation: DISCUSSION (3)
- Lung function measured by impulse oscillometry and spirometry following eucapnic voluntary hyperventilation: DISCUSSION (4)
- Lung function measured by impulse oscillometry and spirometry following eucapnic voluntary hyperventilation: METHODS (1)
- Lung function measured by impulse oscillometry and spirometry following eucapnic voluntary hyperventilation: METHODS (2)
- Lung function measured by impulse oscillometry and spirometry following eucapnic voluntary hyperventilation: RESULTS (1)
- Lung function measured by impulse oscillometry and spirometry following eucapnic voluntary hyperventilation: RESULTS (2)
- Category: Lung Injury
- Category: Men's Health
- Category: Men's Health
- Category: Obstructive Sleep Apnea
- Quality of Life in Patients with Obstructive Sleep Apnea
- Quality of Life in Patients with Obstructive Sleep Apnea: Discussion
- Quality of Life in Patients with Obstructive Sleep Apnea: Materials and Methods
- Quality of Life in Patients with Obstructive Sleep Apnea: nCPAP treatment
- Quality of Life in Patients with Obstructive Sleep Apnea: Results
- Quality of Life in Patients with Obstructive Sleep Apnea: Statistical Analysis
- Treatment of Obstructive Sleep Apnea (1)
- Treatment of Obstructive Sleep Apnea (10)
- Treatment of Obstructive Sleep Apnea (11)
- Treatment of Obstructive Sleep Apnea (12)
- Treatment of Obstructive Sleep Apnea (13)
- Treatment of Obstructive Sleep Apnea (2)
- Treatment of Obstructive Sleep Apnea (3)
- Treatment of Obstructive Sleep Apnea (4)
- Treatment of Obstructive Sleep Apnea (5)
- Treatment of Obstructive Sleep Apnea (6)
- Treatment of Obstructive Sleep Apnea (7)
- Treatment of Obstructive Sleep Apnea (8)
- Treatment of Obstructive Sleep Apnea (9)
- Treatment of Obstructive Sleep Apnea: Discussion (1)
- Treatment of Obstructive Sleep Apnea: Discussion (2)
- Category: Pancreatic carcinoma
- Identifying contraindications to resection in patients with pancreatic carcinoma: CONCLUSIONS Part 1
- Identifying contraindications to resection in patients with pancreatic carcinoma: CONCLUSIONS Part 2
- Identifying contraindications to resection in patients with pancreatic carcinoma: DETERMINATION OF RESECTABILITY Part 1
- Identifying contraindications to resection in patients with pancreatic carcinoma: DETERMINATION OF RESECTABILITY Part 2
- Identifying contraindications to resection in patients with pancreatic carcinoma: DETERMINATION OF RESECTABILITY Part 3
- Identifying contraindications to resection in patients with pancreatic carcinoma: DISTINGUISHING INFLAMMATORY Part 1
- Identifying contraindications to resection in patients with pancreatic carcinoma: DISTINGUISHING INFLAMMATORY Part 2
- Identifying contraindications to resection in patients with pancreatic carcinoma: ESTABLISHING THE DIAGNOSIS Part 1
- Identifying contraindications to resection in patients with pancreatic carcinoma: ESTABLISHING THE DIAGNOSIS Part 2
- Identifying contraindications to resection in patients with pancreatic carcinoma: IDENTIFICATION OF THE MASS LESION
- Identifying contraindications to resection in patients with pancreatic carcinoma: The role of endoscopic ultrasound
- Category: Pneumonitis
- Category: Prednisone therapy
- Resolution of multiple severe colonic strictures with prednisone therapy
- Resolution of multiple severe colonic strictures with prednisone therapy: CASE PRESENTATION (Part 1)
- Resolution of multiple severe colonic strictures with prednisone therapy: CASE PRESENTATION (Part 2)
- Resolution of multiple severe colonic strictures with prednisone therapy: CASE PRESENTATION (Part 3)
- Resolution of multiple severe colonic strictures with prednisone therapy: CONCLUSIONS
- Resolution of multiple severe colonic strictures with prednisone therapy: DISCUSSION (Part 1)
- Resolution of multiple severe colonic strictures with prednisone therapy: DISCUSSION (Part 2)
- Resolution of multiple severe colonic strictures with prednisone therapy: DISCUSSION (Part 3)
- Category: Pseudomonas aeruginosa
- Pseudomonas aeruginosa Compared with Escherichia coli Produces Less Endotoxemia (1)
- Pseudomonas aeruginosa Compared with Escherichia coli Produces Less Endotoxemia (2)
- Pseudomonas aeruginosa Compared with Escherichia coli Produces Less Endotoxemia: Discussion (1)
- Pseudomonas aeruginosa Compared with Escherichia coli Produces Less Endotoxemia: Discussion (2)
- Pseudomonas aeruginosa Compared with Escherichia coli Produces Less Endotoxemia: Discussion (3)
- Pseudomonas aeruginosa Compared with Escherichia coli Produces Less Endotoxemia: Discussion (4)
- Pseudomonas aeruginosa Compared with Escherichia coli Produces Less Endotoxemia: Methods (1)
- Pseudomonas aeruginosa Compared with Escherichia coli Produces Less Endotoxemia: Methods (2)
- Pseudomonas aeruginosa Compared with Escherichia coli Produces Less Endotoxemia: Methods (3)
- Pseudomonas aeruginosa Compared with Escherichia coli Produces Less Endotoxemia: Methods (4)
- Pseudomonas aeruginosa Compared with Escherichia coli Produces Less Endotoxemia: Methods (5)
- Pseudomonas aeruginosa Compared with Escherichia coli Produces Less Endotoxemia: Results (1)
- Pseudomonas aeruginosa Compared with Escherichia coli Produces Less Endotoxemia: Results (2)
- Pseudomonas aeruginosa Compared with Escherichia coli Produces Less Endotoxemia: Results (3)
- Pseudomonas aeruginosa Compared with Escherichia coli Produces Less Endotoxemia: Results (4)
- Category: Pulmonary Artery
- Effect of Acute Changes in Heart Rate on Doppler Pulmonary Artery Acceleration Time in a Porcine Model
- Effect of Acute Changes in Heart Rate on Doppler Pulmonary Artery Acceleration Time in a Porcine Model: Conclusion
- Effect of Acute Changes in Heart Rate on Doppler Pulmonary Artery Acceleration Time in a Porcine Model: Discussion
- Effect of Acute Changes in Heart Rate on Doppler Pulmonary Artery Acceleration Time in a Porcine Model: Results
- Category: Pulmonary Disease
- Metabolic Acidosis during Exercise in Patients with Chronic Obstructive Pulmonary Disease
- Metabolic Acidosis during Exercise in Patients with Chronic Obstructive Pulmonary Disease: Anaerobic threshold is reached
- Metabolic Acidosis during Exercise in Patients with Chronic Obstructive Pulmonary Disease: Conclusion
- Metabolic Acidosis during Exercise in Patients with Chronic Obstructive Pulmonary Disease: Discussion
- Metabolic Acidosis during Exercise in Patients with Chronic Obstructive Pulmonary Disease: Material and Methods
- Metabolic Acidosis during Exercise in Patients with Chronic Obstructive Pulmonary Disease: Patients with COPD
- Metabolic Acidosis during Exercise in Patients with Chronic Obstructive Pulmonary Disease: Results
- Category: Pulmonary Fibrosis
- Colchicine, D-Penicillamine, and Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis
- Colchicine, D-Penicillamine, and Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis: Conclusion
- Colchicine, D-Penicillamine, and Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis: Discussion
- Colchicine, D-Penicillamine, and Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis: Materials and Methods
- Colchicine, D-Penicillamine, and Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis: Outcome
- Colchicine, D-Penicillamine, and Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis: Results
- Colchicine, D-Penicillamine, and Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis: Semiquantitative Histologic Assessment
- Colchicine, D-Penicillamine, and Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis: Statistical Analyses
- Category: Pulmonary Function
- Advances in Pulmonary Laboratory Testing
- Advances in Pulmonary Laboratory Testing: Assessment of Expiratory Flow Limitation
- Advances in Pulmonary Laboratory Testing: Clinical Application
- Advances in Pulmonary Laboratory Testing: Clinical Application
- Advances in Pulmonary Laboratory Testing: Exhaled NO
- Advances in Pulmonary Laboratory Testing: Exhaled NO Measurement
- Advances in Pulmonary Laboratory Testing: FO technique
- Advances in Pulmonary Laboratory Testing: Laboratory Requirements
- Advances in Pulmonary Laboratory Testing: Laboratory Requirements
- Advances in Pulmonary Laboratory Testing: Methodology
- Advances in Pulmonary Laboratory Testing: Negative Expiratory Pressures
- Advances in Pulmonary Laboratory Testing: NEP
- Advances in Pulmonary Laboratory Testing: Plethysmography
- Category: Pulmonary Hypertension
- Canadian Neighbor Pharmacy: Discussion of Bosentan Improves Exercise Tolerance and Tei Index in Patients With Pulmonary Hypertension and Prostanoid Therapy
- Circulating von Willebrand Factor Antigen as a Predictor of Short-term Prognosis in Pulmonary Hypertension
- Circulating von Willebrand Factor Antigen as a Predictor of Short-term Prognosis in Pulmonary Hypertension: Blood Sampling and Inhibition of Proteolysis In Vitro
- Circulating von Willebrand Factor Antigen as a Predictor of Short-term Prognosis in Pulmonary Hypertension: Conclusion
- Circulating von Willebrand Factor Antigen as a Predictor of Short-term Prognosis in Pulmonary Hypertension: Congenital heart disease
- Circulating von Willebrand Factor Antigen as a Predictor of Short-term Prognosis in Pulmonary Hypertension: Discussion
- Circulating von Willebrand Factor Antigen as a Predictor of Short-term Prognosis in Pulmonary Hypertension: Materials and Methods
- Circulating von Willebrand Factor Antigen as a Predictor of Short-term Prognosis in Pulmonary Hypertension: Outcome
- Circulating von Willebrand Factor Antigen as a Predictor of Short-term Prognosis in Pulmonary Hypertension: Plasma von Willebrand Factor Biological Activity
- Circulating von Willebrand Factor Antigen as a Predictor of Short-term Prognosis in Pulmonary Hypertension: Results
- Circulating von Willebrand Factor Antigen as a Predictor of Short-term Prognosis in Pulmonary Hypertension: The likelihood of fatal outcome
- Pulmonary Vascular Remodeling in Neonatal Pulmonary Hypertension
- Pulmonary Vascular Remodeling in Neonatal Pulmonary Hypertension: Adaptation to Extrauterine LAfe
Plugin by dagondesign.com